Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 14;24(16):12782.
doi: 10.3390/ijms241612782.

The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases

Mónika Szilveszter  1 , Sándor Pál  2 , Zsuzsánna Simon-Szabó  3 , Orsolya-Zsuzsa Akácsos-Szász  4 , Mihály Moldován  5 , Barbara Réger  6 , Lóránd Dénes  7 , Zsuzsanna Faust  2 , Mariana Cornelia Tilinca  8 , Enikő Nemes-Nagy  9
Affiliations
Review

The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases

Mónika Szilveszter et al. Int J Mol Sci. .

Abstract

The course of COVID-19 is highly dependent on the associated cardiometabolic comorbidities of the patient, which worsen the prognosis of coronavirus infection, mainly due to systemic inflammation, endothelium dysfunction, and thrombosis. A search on the recent medical literature was performed in five languages, using the PubMed, Embase, Cochrane, and Google Scholar databases, for the review of data regarding the management of patients with a high risk for severe COVID-19, focusing on the associated coagulopathy. Special features of COVID-19 management are presented, based on the underlying conditions (obesity, diabetes mellitus, and cardiovascular diseases), emphasizing the necessity of a modern, holistic approach to thromboembolic states. The latest findings regarding the most efficient therapeutic approaches are included in the article, offering guidance for medical professionals in severe, complicated cases of SARS-CoV-2 infection. We can conclude that severe COVID-19 is closely related to vascular inflammation and intense cytokine release leading to hemostasis disorders. Overweight, hyperglycemia, cardiovascular diseases, and old age are important risk factors for severe outcomes of coronavirus infection, involving a hypercoagulable state. Early diagnosis and proper therapy in complicated SARS-CoV-2-infected cases could reduce mortality and the need for intensive care during hospitalization in patients with cardiometabolic comorbidities.

Keywords: COVID-19; cardiovascular diseases; coagulopathy; diabetes mellitus; hypercoagulable state; obesity; stroke; thrombosis; venous thromboembolism; viscoelastometry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The management of COVID-19.
See this image and copyright information in PMC

References

    1. Djaharuddin I., Munawwarah S., Nurulita A., Ilyas M., Tabri N.A., Lihawa N. Comorbidities and mortality in COVID-19 patients. Gac. Sanit. 2021;35:S530–S532. doi: 10.1016/j.gaceta.2021.10.085. - DOI - PMC - PubMed
    1. Fekete M., Szarvas Z., Fazekas-Pongor V., Kováts Z., Müller V., Varga J.T. Ambuláns rehabilitációs programok COVID–19-betegek számára (Outpatient rehabilitation programs for COVID-19 patients) Orvosi Hetil. 2021;162:1671–1677. - PubMed
    1. Mureșan A.V., Russu E., Arbănași E.M., Kaller R., Hosu I., Arbănași E.M., Voidăzan S.T. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania. J. Clin. Med. 2022;11:2452. - PMC - PubMed
    1. Wu Z., McGoogan J. Outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–1242. - PubMed
    1. Li Y., Zhang Z., Yang L., Lian X., Xie Y., Li S., Xin S., Cao P., Lu J. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. Iscience. 2020;23:101160. - PMC - PubMed